nodes	percent_of_prediction	percent_of_DWPC	metapath
Glycine—GATM—coronary artery disease	0.59	1	CbGaD
Glycine—SLC6A9—heart—coronary artery disease	0.00254	0.0384	CbGeAlD
Glycine—ALAS2—heart—coronary artery disease	0.00239	0.0361	CbGeAlD
Glycine—GCAT—cardiac ventricle—coronary artery disease	0.00237	0.0357	CbGeAlD
Glycine—GCAT—myocardium—coronary artery disease	0.00223	0.0336	CbGeAlD
Glycine—GLYATL2—blood—coronary artery disease	0.00213	0.0321	CbGeAlD
Glycine—ALAS1—cardiac ventricle—coronary artery disease	0.00208	0.0313	CbGeAlD
Glycine—GCSH—heart—coronary artery disease	0.00207	0.0313	CbGeAlD
Glycine—ALAS1—myocardium—coronary artery disease	0.00195	0.0295	CbGeAlD
Glycine—Aminocaproic Acid—PLG—coronary artery disease	0.0019	0.314	CrCbGaD
Glycine—GARS—cardiac ventricle—coronary artery disease	0.00189	0.0285	CbGeAlD
Glycine—GNMT—heart—coronary artery disease	0.00181	0.0273	CbGeAlD
Glycine—GATM—cardiac ventricle—coronary artery disease	0.00179	0.0271	CbGeAlD
Glycine—ALAS2—blood—coronary artery disease	0.00178	0.0269	CbGeAlD
Glycine—GARS—myocardium—coronary artery disease	0.00178	0.0268	CbGeAlD
Glycine—GATM—myocardium—coronary artery disease	0.00169	0.0255	CbGeAlD
Glycine—GPR18—blood—coronary artery disease	0.00165	0.0249	CbGeAlD
Glycine—SHMT2—cardiac ventricle—coronary artery disease	0.00164	0.0248	CbGeAlD
Glycine—Aminocaproic Acid—PLAT—coronary artery disease	0.00161	0.267	CrCbGaD
Glycine—PIPOX—heart—coronary artery disease	0.0016	0.0242	CbGeAlD
Glycine—GCAT—heart—coronary artery disease	0.00156	0.0235	CbGeAlD
Glycine—SHMT1—myocardium—coronary artery disease	0.00141	0.0213	CbGeAlD
Glycine—ALAS1—heart—coronary artery disease	0.00136	0.0206	CbGeAlD
Glycine—GNMT—blood—coronary artery disease	0.00135	0.0204	CbGeAlD
Glycine—L-Cysteine—GCLM—coronary artery disease	0.00131	0.218	CrCbGaD
Glycine—ALAS1—cardiovascular system—coronary artery disease	0.00129	0.0194	CbGeAlD
Glycine—GLDC—blood—coronary artery disease	0.00128	0.0193	CbGeAlD
Glycine—GARS—heart—coronary artery disease	0.00124	0.0187	CbGeAlD
Glycine—PIPOX—blood—coronary artery disease	0.0012	0.0181	CbGeAlD
Glycine—GATM—heart—coronary artery disease	0.00118	0.0178	CbGeAlD
Glycine—GARS—cardiovascular system—coronary artery disease	0.00117	0.0177	CbGeAlD
Glycine—ALAS1—cardiac atrium—coronary artery disease	0.00117	0.0176	CbGeAlD
Glycine—GCAT—blood—coronary artery disease	0.00116	0.0175	CbGeAlD
Glycine—GSS—cardiac ventricle—coronary artery disease	0.00112	0.017	CbGeAlD
Glycine—SHMT2—heart—coronary artery disease	0.00108	0.0163	CbGeAlD
Glycine—GARS—cardiac atrium—coronary artery disease	0.00106	0.016	CbGeAlD
Glycine—GSS—myocardium—coronary artery disease	0.00106	0.016	CbGeAlD
Glycine—SHMT2—cardiovascular system—coronary artery disease	0.00102	0.0154	CbGeAlD
Glycine—ALAS1—blood—coronary artery disease	0.00102	0.0154	CbGeAlD
Glycine—GLRB—heart—coronary artery disease	0.00101	0.0153	CbGeAlD
Glycine—GATM—cardiac atrium—coronary artery disease	0.00101	0.0152	CbGeAlD
Glycine—ALAS1—Lisinopril—Enalapril—coronary artery disease	0.000997	0.199	CbGdCrCtD
Glycine—ALAS1—Lisinopril—Trandolapril—coronary artery disease	0.000997	0.199	CbGdCrCtD
Glycine—SHMT1—heart—coronary artery disease	0.000983	0.0148	CbGeAlD
Glycine—GLRB—cardiovascular system—coronary artery disease	0.000955	0.0144	CbGeAlD
Glycine—GARS—blood—coronary artery disease	0.000926	0.014	CbGeAlD
Glycine—GRIN2A—heart—coronary artery disease	0.000844	0.0127	CbGeAlD
Glycine—SLC36A1—heart—coronary artery disease	0.000839	0.0127	CbGeAlD
Glycine—SHMT2—blood—coronary artery disease	0.000806	0.0122	CbGeAlD
Glycine—ALAS1—Lisinopril—Ramipril—coronary artery disease	0.000755	0.151	CbGdCrCtD
Glycine—GSS—heart—coronary artery disease	0.000738	0.0111	CbGeAlD
Glycine—SHMT1—blood—coronary artery disease	0.000734	0.0111	CbGeAlD
Glycine—GSS—cardiovascular system—coronary artery disease	0.000697	0.0105	CbGeAlD
Glycine—L-Cysteine—GCLC—coronary artery disease	0.00069	0.114	CrCbGaD
Glycine—ALAS1—Candesartan—Telmisartan—coronary artery disease	0.000684	0.137	CbGdCrCtD
Glycine—GSS—cardiac atrium—coronary artery disease	0.000631	0.00953	CbGeAlD
Glycine—ALAS1—Candesartan—Olmesartan—coronary artery disease	0.000567	0.113	CbGdCrCtD
Glycine—GSS—blood—coronary artery disease	0.000551	0.00832	CbGeAlD
Glycine—ALAS1—Candesartan—Valsartan—coronary artery disease	0.000541	0.108	CbGdCrCtD
Glycine—L-Cysteine—GOT1—coronary artery disease	0.000523	0.0867	CrCbGaD
Glycine—ALAS1—Candesartan—Losartan—coronary artery disease	0.00046	0.092	CbGdCrCtD
Glycine—SLC16A10—blood—coronary artery disease	0.000404	0.00609	CbGeAlD
Glycine—Rhinitis—Captopril—coronary artery disease	0.000348	0.00279	CcSEcCtD
Glycine—Vertigo—Lovastatin—coronary artery disease	0.000346	0.00278	CcSEcCtD
Glycine—Visual impairment—Telmisartan—coronary artery disease	0.000344	0.00276	CcSEcCtD
Glycine—Chills—Niacin—coronary artery disease	0.000341	0.00274	CcSEcCtD
Glycine—Vision blurred—Simvastatin—coronary artery disease	0.00034	0.00272	CcSEcCtD
Glycine—Diarrhoea—Penbutolol—coronary artery disease	0.000339	0.00271	CcSEcCtD
Glycine—Rhinitis—Perindopril—coronary artery disease	0.000338	0.00271	CcSEcCtD
Glycine—Chills—Pravastatin—coronary artery disease	0.000336	0.00269	CcSEcCtD
Glycine—Urticaria—Gemfibrozil—coronary artery disease	0.000335	0.00269	CcSEcCtD
Glycine—Dehydration—Lisinopril—coronary artery disease	0.000331	0.00265	CcSEcCtD
Glycine—Angina pectoris—Ramipril—coronary artery disease	0.00033	0.00265	CcSEcCtD
Glycine—Back pain—Valsartan—coronary artery disease	0.000329	0.00264	CcSEcCtD
Glycine—Back pain—Olmesartan—coronary artery disease	0.000328	0.00263	CcSEcCtD
Glycine—Dizziness—Penbutolol—coronary artery disease	0.000327	0.00262	CcSEcCtD
Glycine—Visual impairment—Perindopril—coronary artery disease	0.000325	0.00261	CcSEcCtD
Glycine—Vertigo—Simvastatin—coronary artery disease	0.000324	0.0026	CcSEcCtD
Glycine—Angina pectoris—Timolol—coronary artery disease	0.000323	0.00259	CcSEcCtD
Glycine—Oedema—Fenofibrate—coronary artery disease	0.000322	0.00258	CcSEcCtD
Glycine—Vision blurred—Valsartan—coronary artery disease	0.000321	0.00257	CcSEcCtD
Glycine—Chills—Telmisartan—coronary artery disease	0.000321	0.00257	CcSEcCtD
Glycine—Vision blurred—Olmesartan—coronary artery disease	0.000319	0.00256	CcSEcCtD
Glycine—Pain—Rosuvastatin—coronary artery disease	0.000318	0.00254	CcSEcCtD
Glycine—Rhinitis—Losartan—coronary artery disease	0.000317	0.00254	CcSEcCtD
Glycine—Oedema—Clopidogrel—coronary artery disease	0.000317	0.00254	CcSEcCtD
Glycine—Visual impairment—Furosemide—coronary artery disease	0.000316	0.00253	CcSEcCtD
Glycine—Tachycardia—Fenofibrate—coronary artery disease	0.000315	0.00252	CcSEcCtD
Glycine—Vision blurred—Niacin—coronary artery disease	0.000312	0.0025	CcSEcCtD
Glycine—Vision blurred—Pravastatin—coronary artery disease	0.000307	0.00246	CcSEcCtD
Glycine—Back pain—Trandolapril—coronary artery disease	0.000306	0.00245	CcSEcCtD
Glycine—Vertigo—Valsartan—coronary artery disease	0.000306	0.00245	CcSEcCtD
Glycine—Back pain—Enalapril—coronary artery disease	0.000305	0.00244	CcSEcCtD
Glycine—Vertigo—Olmesartan—coronary artery disease	0.000305	0.00244	CcSEcCtD
Glycine—Hypersensitivity—Ticagrelor—coronary artery disease	0.000304	0.00244	CcSEcCtD
Glycine—Chills—Perindopril—coronary artery disease	0.000303	0.00243	CcSEcCtD
Glycine—Hypotension—Fenofibrate—coronary artery disease	0.000301	0.00241	CcSEcCtD
Glycine—Back pain—Telmisartan—coronary artery disease	0.000301	0.00241	CcSEcCtD
Glycine—Angina pectoris—Lisinopril—coronary artery disease	0.000299	0.0024	CcSEcCtD
Glycine—Vertigo—Niacin—coronary artery disease	0.000298	0.00238	CcSEcCtD
Glycine—Vision blurred—Enalapril—coronary artery disease	0.000297	0.00238	CcSEcCtD
Glycine—Hypotension—Clopidogrel—coronary artery disease	0.000296	0.00237	CcSEcCtD
Glycine—Urticaria—Rosuvastatin—coronary artery disease	0.000295	0.00236	CcSEcCtD
Glycine—Oedema—Simvastatin—coronary artery disease	0.000294	0.00236	CcSEcCtD
Glycine—Nausea—Penbutolol—coronary artery disease	0.000294	0.00236	CcSEcCtD
Glycine—Vertigo—Pravastatin—coronary artery disease	0.000293	0.00235	CcSEcCtD
Glycine—Diarrhoea—Gemfibrozil—coronary artery disease	0.000289	0.00232	CcSEcCtD
Glycine—Urticaria—Acetylsalicylic acid—coronary artery disease	0.000287	0.0023	CcSEcCtD
Glycine—Vision blurred—Captopril—coronary artery disease	0.000285	0.00228	CcSEcCtD
Glycine—Vertigo—Trandolapril—coronary artery disease	0.000284	0.00228	CcSEcCtD
Glycine—Back pain—Perindopril—coronary artery disease	0.000284	0.00228	CcSEcCtD
Glycine—Vertigo—Enalapril—coronary artery disease	0.000283	0.00227	CcSEcCtD
Glycine—Hypotension—Eplerenone—coronary artery disease	0.000282	0.00226	CcSEcCtD
Glycine—Diarrhoea—Ticagrelor—coronary artery disease	0.000282	0.00226	CcSEcCtD
Glycine—Vertigo—Telmisartan—coronary artery disease	0.000279	0.00224	CcSEcCtD
Glycine—Dizziness—Gemfibrozil—coronary artery disease	0.000279	0.00224	CcSEcCtD
Glycine—Oedema—Valsartan—coronary artery disease	0.000278	0.00223	CcSEcCtD
Glycine—Oedema—Olmesartan—coronary artery disease	0.000277	0.00222	CcSEcCtD
Glycine—Pain—Fenofibrate—coronary artery disease	0.000276	0.00221	CcSEcCtD
Glycine—Hypersensitivity—Rosuvastatin—coronary artery disease	0.000274	0.00219	CcSEcCtD
Glycine—Dizziness—Ticagrelor—coronary artery disease	0.000273	0.00219	CcSEcCtD
Glycine—Pain—Clopidogrel—coronary artery disease	0.000271	0.00217	CcSEcCtD
Glycine—Oedema—Niacin—coronary artery disease	0.00027	0.00217	CcSEcCtD
Glycine—Tachycardia—Olmesartan—coronary artery disease	0.00027	0.00216	CcSEcCtD
Glycine—Pain—Lovastatin—coronary artery disease	0.000269	0.00216	CcSEcCtD
Glycine—Vision blurred—Furosemide—coronary artery disease	0.000269	0.00216	CcSEcCtD
Glycine—Vomiting—Gemfibrozil—coronary artery disease	0.000268	0.00215	CcSEcCtD
Glycine—Back pain—Losartan—coronary artery disease	0.000266	0.00214	CcSEcCtD
Glycine—Oedema—Pravastatin—coronary artery disease	0.000266	0.00213	CcSEcCtD
Glycine—Rhinitis—Timolol—coronary artery disease	0.000266	0.00213	CcSEcCtD
Glycine—Hypersensitivity—Acetylsalicylic acid—coronary artery disease	0.000266	0.00213	CcSEcCtD
Glycine—Pain—Ezetimibe—coronary artery disease	0.000264	0.00212	CcSEcCtD
Glycine—Vertigo—Perindopril—coronary artery disease	0.000264	0.00211	CcSEcCtD
Glycine—Tachycardia—Niacin—coronary artery disease	0.000264	0.00211	CcSEcCtD
Glycine—Vomiting—Ticagrelor—coronary artery disease	0.000262	0.0021	CcSEcCtD
Glycine—Visual impairment—Ramipril—coronary artery disease	0.000261	0.0021	CcSEcCtD
Glycine—Hypotension—Valsartan—coronary artery disease	0.00026	0.00208	CcSEcCtD
Glycine—Vision blurred—Losartan—coronary artery disease	0.00026	0.00208	CcSEcCtD
Glycine—Hypotension—Olmesartan—coronary artery disease	0.000258	0.00207	CcSEcCtD
Glycine—Oedema—Trandolapril—coronary artery disease	0.000258	0.00207	CcSEcCtD
Glycine—Pain—Eplerenone—coronary artery disease	0.000258	0.00207	CcSEcCtD
Glycine—Oedema—Enalapril—coronary artery disease	0.000257	0.00206	CcSEcCtD
Glycine—Vertigo—Furosemide—coronary artery disease	0.000256	0.00206	CcSEcCtD
Glycine—Urticaria—Fenofibrate—coronary artery disease	0.000256	0.00205	CcSEcCtD
Glycine—Visual impairment—Timolol—coronary artery disease	0.000256	0.00205	CcSEcCtD
Glycine—Diarrhoea—Rosuvastatin—coronary artery disease	0.000254	0.00204	CcSEcCtD
Glycine—Oedema—Telmisartan—coronary artery disease	0.000254	0.00203	CcSEcCtD
Glycine—Hypotension—Niacin—coronary artery disease	0.000253	0.00202	CcSEcCtD
Glycine—Tachycardia—Trandolapril—coronary artery disease	0.000252	0.00202	CcSEcCtD
Glycine—Pain—Simvastatin—coronary artery disease	0.000252	0.00202	CcSEcCtD
Glycine—Urticaria—Clopidogrel—coronary artery disease	0.000252	0.00202	CcSEcCtD
Glycine—Tachycardia—Enalapril—coronary artery disease	0.000251	0.00201	CcSEcCtD
Glycine—Nausea—Gemfibrozil—coronary artery disease	0.000251	0.00201	CcSEcCtD
Glycine—Urticaria—Lovastatin—coronary artery disease	0.00025	0.002	CcSEcCtD
Glycine—Tachycardia—Telmisartan—coronary artery disease	0.000248	0.00199	CcSEcCtD
Glycine—Vertigo—Losartan—coronary artery disease	0.000247	0.00198	CcSEcCtD
Glycine—Diarrhoea—Acetylsalicylic acid—coronary artery disease	0.000247	0.00198	CcSEcCtD
Glycine—Rhinitis—Lisinopril—coronary artery disease	0.000247	0.00198	CcSEcCtD
Glycine—Dizziness—Rosuvastatin—coronary artery disease	0.000246	0.00197	CcSEcCtD
Glycine—Urticaria—Ezetimibe—coronary artery disease	0.000245	0.00197	CcSEcCtD
Glycine—Nausea—Ticagrelor—coronary artery disease	0.000245	0.00196	CcSEcCtD
Glycine—Hypotension—Trandolapril—coronary artery disease	0.000241	0.00194	CcSEcCtD
Glycine—Tachycardia—Captopril—coronary artery disease	0.000241	0.00193	CcSEcCtD
Glycine—Hypotension—Enalapril—coronary artery disease	0.00024	0.00193	CcSEcCtD
Glycine—Oedema—Perindopril—coronary artery disease	0.00024	0.00192	CcSEcCtD
Glycine—Dizziness—Acetylsalicylic acid—coronary artery disease	0.000239	0.00191	CcSEcCtD
Glycine—Hypersensitivity—Fenofibrate—coronary artery disease	0.000237	0.0019	CcSEcCtD
Glycine—Hypotension—Telmisartan—coronary artery disease	0.000237	0.0019	CcSEcCtD
Glycine—Pain—Olmesartan—coronary artery disease	0.000237	0.0019	CcSEcCtD
Glycine—Tachycardia—Perindopril—coronary artery disease	0.000234	0.00187	CcSEcCtD
Glycine—Urticaria—Simvastatin—coronary artery disease	0.000234	0.00187	CcSEcCtD
Glycine—Hypersensitivity—Clopidogrel—coronary artery disease	0.000233	0.00187	CcSEcCtD
Glycine—Hypersensitivity—Lovastatin—coronary artery disease	0.000232	0.00186	CcSEcCtD
Glycine—Pain—Niacin—coronary artery disease	0.000231	0.00185	CcSEcCtD
Glycine—Hypotension—Captopril—coronary artery disease	0.000231	0.00185	CcSEcCtD
Glycine—Vomiting—Acetylsalicylic acid—coronary artery disease	0.000229	0.00184	CcSEcCtD
Glycine—Pain—Pravastatin—coronary artery disease	0.000228	0.00182	CcSEcCtD
Glycine—Hypersensitivity—Ezetimibe—coronary artery disease	0.000227	0.00182	CcSEcCtD
Glycine—Oedema—Losartan—coronary artery disease	0.000225	0.0018	CcSEcCtD
Glycine—Hypotension—Perindopril—coronary artery disease	0.000224	0.00179	CcSEcCtD
Glycine—Urticaria—Valsartan—coronary artery disease	0.000221	0.00177	CcSEcCtD
Glycine—Chills—Lisinopril—coronary artery disease	0.000221	0.00177	CcSEcCtD
Glycine—Nausea—Rosuvastatin—coronary artery disease	0.000221	0.00177	CcSEcCtD
Glycine—Diarrhoea—Fenofibrate—coronary artery disease	0.00022	0.00177	CcSEcCtD
Glycine—Urticaria—Olmesartan—coronary artery disease	0.00022	0.00176	CcSEcCtD
Glycine—Tachycardia—Losartan—coronary artery disease	0.000219	0.00176	CcSEcCtD
Glycine—Hypotension—Furosemide—coronary artery disease	0.000218	0.00174	CcSEcCtD
Glycine—Vision blurred—Timolol—coronary artery disease	0.000218	0.00174	CcSEcCtD
Glycine—Pain—Telmisartan—coronary artery disease	0.000217	0.00174	CcSEcCtD
Glycine—Hypersensitivity—Simvastatin—coronary artery disease	0.000217	0.00174	CcSEcCtD
Glycine—Diarrhoea—Clopidogrel—coronary artery disease	0.000217	0.00174	CcSEcCtD
Glycine—Diarrhoea—Lovastatin—coronary artery disease	0.000215	0.00173	CcSEcCtD
Glycine—Urticaria—Niacin—coronary artery disease	0.000215	0.00172	CcSEcCtD
Glycine—Nausea—Acetylsalicylic acid—coronary artery disease	0.000214	0.00172	CcSEcCtD
Glycine—Dizziness—Fenofibrate—coronary artery disease	0.000213	0.00171	CcSEcCtD
Glycine—Vertigo—Ramipril—coronary artery disease	0.000212	0.0017	CcSEcCtD
Glycine—Urticaria—Pravastatin—coronary artery disease	0.000211	0.00169	CcSEcCtD
Glycine—Diarrhoea—Ezetimibe—coronary artery disease	0.000211	0.00169	CcSEcCtD
Glycine—Hypotension—Losartan—coronary artery disease	0.00021	0.00168	CcSEcCtD
Glycine—Dizziness—Clopidogrel—coronary artery disease	0.000209	0.00168	CcSEcCtD
Glycine—Dizziness—Lovastatin—coronary artery disease	0.000208	0.00167	CcSEcCtD
Glycine—Vertigo—Timolol—coronary artery disease	0.000207	0.00166	CcSEcCtD
Glycine—Back pain—Lisinopril—coronary artery disease	0.000207	0.00166	CcSEcCtD
Glycine—Diarrhoea—Eplerenone—coronary artery disease	0.000207	0.00166	CcSEcCtD
Glycine—Urticaria—Trandolapril—coronary artery disease	0.000205	0.00165	CcSEcCtD
Glycine—Pain—Perindopril—coronary artery disease	0.000205	0.00164	CcSEcCtD
Glycine—Vomiting—Fenofibrate—coronary artery disease	0.000205	0.00164	CcSEcCtD
Glycine—Hypersensitivity—Valsartan—coronary artery disease	0.000205	0.00164	CcSEcCtD
Glycine—Convulsion—Ramipril—coronary artery disease	0.000205	0.00164	CcSEcCtD
Glycine—Urticaria—Enalapril—coronary artery disease	0.000204	0.00164	CcSEcCtD
Glycine—Dizziness—Ezetimibe—coronary artery disease	0.000204	0.00164	CcSEcCtD
Glycine—Vision blurred—Lisinopril—coronary artery disease	0.000202	0.00162	CcSEcCtD
Glycine—Urticaria—Telmisartan—coronary artery disease	0.000202	0.00162	CcSEcCtD
Glycine—Vomiting—Clopidogrel—coronary artery disease	0.000201	0.00161	CcSEcCtD
Glycine—Diarrhoea—Simvastatin—coronary artery disease	0.000201	0.00161	CcSEcCtD
Glycine—Vomiting—Lovastatin—coronary artery disease	0.0002	0.0016	CcSEcCtD
Glycine—Dizziness—Eplerenone—coronary artery disease	0.0002	0.0016	CcSEcCtD
Glycine—Pain—Furosemide—coronary artery disease	0.000199	0.0016	CcSEcCtD
Glycine—Hypersensitivity—Niacin—coronary artery disease	0.000199	0.0016	CcSEcCtD
Glycine—Vomiting—Ezetimibe—coronary artery disease	0.000196	0.00157	CcSEcCtD
Glycine—Hypersensitivity—Pravastatin—coronary artery disease	0.000196	0.00157	CcSEcCtD
Glycine—Dizziness—Simvastatin—coronary artery disease	0.000195	0.00156	CcSEcCtD
Glycine—Oedema—Ramipril—coronary artery disease	0.000193	0.00154	CcSEcCtD
Glycine—Vertigo—Lisinopril—coronary artery disease	0.000192	0.00154	CcSEcCtD
Glycine—Pain—Losartan—coronary artery disease	0.000192	0.00154	CcSEcCtD
Glycine—Vomiting—Eplerenone—coronary artery disease	0.000192	0.00154	CcSEcCtD
Glycine—Nausea—Fenofibrate—coronary artery disease	0.000191	0.00153	CcSEcCtD
Glycine—Urticaria—Perindopril—coronary artery disease	0.00019	0.00153	CcSEcCtD
Glycine—Hypersensitivity—Trandolapril—coronary artery disease	0.00019	0.00153	CcSEcCtD
Glycine—Diarrhoea—Valsartan—coronary artery disease	0.00019	0.00152	CcSEcCtD
Glycine—Hypersensitivity—Enalapril—coronary artery disease	0.00019	0.00152	CcSEcCtD
Glycine—Diarrhoea—Olmesartan—coronary artery disease	0.000189	0.00152	CcSEcCtD
Glycine—Oedema—Timolol—coronary artery disease	0.000188	0.00151	CcSEcCtD
Glycine—Nausea—Clopidogrel—coronary artery disease	0.000188	0.00151	CcSEcCtD
Glycine—Tachycardia—Ramipril—coronary artery disease	0.000188	0.00151	CcSEcCtD
Glycine—Vomiting—Simvastatin—coronary artery disease	0.000187	0.0015	CcSEcCtD
Glycine—Hypersensitivity—Telmisartan—coronary artery disease	0.000187	0.0015	CcSEcCtD
Glycine—Nausea—Lovastatin—coronary artery disease	0.000187	0.0015	CcSEcCtD
Glycine—Urticaria—Furosemide—coronary artery disease	0.000185	0.00148	CcSEcCtD
Glycine—Diarrhoea—Niacin—coronary artery disease	0.000185	0.00148	CcSEcCtD
Glycine—Dizziness—Valsartan—coronary artery disease	0.000184	0.00147	CcSEcCtD
Glycine—Nausea—Ezetimibe—coronary artery disease	0.000183	0.00147	CcSEcCtD
Glycine—Dizziness—Olmesartan—coronary artery disease	0.000183	0.00147	CcSEcCtD
Glycine—Diarrhoea—Pravastatin—coronary artery disease	0.000182	0.00146	CcSEcCtD
Glycine—Hypotension—Ramipril—coronary artery disease	0.00018	0.00144	CcSEcCtD
Glycine—Nausea—Eplerenone—coronary artery disease	0.000179	0.00144	CcSEcCtD
Glycine—Dizziness—Niacin—coronary artery disease	0.000179	0.00143	CcSEcCtD
Glycine—Urticaria—Losartan—coronary artery disease	0.000179	0.00143	CcSEcCtD
Glycine—Diarrhoea—Trandolapril—coronary artery disease	0.000177	0.00142	CcSEcCtD
Glycine—Vomiting—Valsartan—coronary artery disease	0.000177	0.00142	CcSEcCtD
Glycine—Diarrhoea—Enalapril—coronary artery disease	0.000176	0.00141	CcSEcCtD
Glycine—Hypotension—Timolol—coronary artery disease	0.000176	0.00141	CcSEcCtD
Glycine—Dizziness—Pravastatin—coronary artery disease	0.000176	0.00141	CcSEcCtD
Glycine—Vomiting—Olmesartan—coronary artery disease	0.000176	0.00141	CcSEcCtD
Glycine—Nausea—Simvastatin—coronary artery disease	0.000175	0.0014	CcSEcCtD
Glycine—Oedema—Lisinopril—coronary artery disease	0.000175	0.0014	CcSEcCtD
Glycine—Diarrhoea—Telmisartan—coronary artery disease	0.000174	0.00139	CcSEcCtD
Glycine—Vomiting—Niacin—coronary artery disease	0.000172	0.00138	CcSEcCtD
Glycine—Hypersensitivity—Furosemide—coronary artery disease	0.000172	0.00138	CcSEcCtD
Glycine—Dizziness—Trandolapril—coronary artery disease	0.000171	0.00137	CcSEcCtD
Glycine—Tachycardia—Lisinopril—coronary artery disease	0.000171	0.00137	CcSEcCtD
Glycine—Dizziness—Enalapril—coronary artery disease	0.00017	0.00136	CcSEcCtD
Glycine—Vomiting—Pravastatin—coronary artery disease	0.000169	0.00136	CcSEcCtD
Glycine—Diarrhoea—Captopril—coronary artery disease	0.000169	0.00135	CcSEcCtD
Glycine—Dizziness—Telmisartan—coronary artery disease	0.000168	0.00135	CcSEcCtD
Glycine—Hypersensitivity—Losartan—coronary artery disease	0.000166	0.00133	CcSEcCtD
Glycine—Nausea—Valsartan—coronary artery disease	0.000165	0.00132	CcSEcCtD
Glycine—Nausea—Olmesartan—coronary artery disease	0.000164	0.00132	CcSEcCtD
Glycine—Vomiting—Trandolapril—coronary artery disease	0.000164	0.00132	CcSEcCtD
Glycine—Diarrhoea—Perindopril—coronary artery disease	0.000164	0.00131	CcSEcCtD
Glycine—Vomiting—Enalapril—coronary artery disease	0.000164	0.00131	CcSEcCtD
Glycine—Hypotension—Lisinopril—coronary artery disease	0.000163	0.00131	CcSEcCtD
Glycine—Dizziness—Captopril—coronary artery disease	0.000163	0.00131	CcSEcCtD
Glycine—Vomiting—Telmisartan—coronary artery disease	0.000161	0.00129	CcSEcCtD
Glycine—Pain—Timolol—coronary artery disease	0.000161	0.00129	CcSEcCtD
Glycine—Nausea—Niacin—coronary artery disease	0.000161	0.00129	CcSEcCtD
Glycine—Diarrhoea—Furosemide—coronary artery disease	0.000159	0.00128	CcSEcCtD
Glycine—Dizziness—Perindopril—coronary artery disease	0.000158	0.00127	CcSEcCtD
Glycine—Nausea—Pravastatin—coronary artery disease	0.000158	0.00127	CcSEcCtD
Glycine—Vomiting—Captopril—coronary artery disease	0.000157	0.00126	CcSEcCtD
Glycine—Dizziness—Furosemide—coronary artery disease	0.000154	0.00123	CcSEcCtD
Glycine—Diarrhoea—Losartan—coronary artery disease	0.000154	0.00123	CcSEcCtD
Glycine—Nausea—Trandolapril—coronary artery disease	0.000153	0.00123	CcSEcCtD
Glycine—Urticaria—Ramipril—coronary artery disease	0.000153	0.00123	CcSEcCtD
Glycine—Nausea—Enalapril—coronary artery disease	0.000153	0.00123	CcSEcCtD
Glycine—Vomiting—Perindopril—coronary artery disease	0.000152	0.00122	CcSEcCtD
Glycine—Nausea—Telmisartan—coronary artery disease	0.000151	0.00121	CcSEcCtD
Glycine—Urticaria—Timolol—coronary artery disease	0.00015	0.0012	CcSEcCtD
Glycine—Pain—Lisinopril—coronary artery disease	0.000149	0.0012	CcSEcCtD
Glycine—Dizziness—Losartan—coronary artery disease	0.000149	0.00119	CcSEcCtD
Glycine—Vomiting—Furosemide—coronary artery disease	0.000148	0.00119	CcSEcCtD
Glycine—Nausea—Captopril—coronary artery disease	0.000147	0.00118	CcSEcCtD
Glycine—Vomiting—Losartan—coronary artery disease	0.000143	0.00115	CcSEcCtD
Glycine—Nausea—Perindopril—coronary artery disease	0.000142	0.00114	CcSEcCtD
Glycine—Hypersensitivity—Ramipril—coronary artery disease	0.000142	0.00114	CcSEcCtD
Glycine—Urticaria—Lisinopril—coronary artery disease	0.000139	0.00111	CcSEcCtD
Glycine—Hypersensitivity—Timolol—coronary artery disease	0.000139	0.00111	CcSEcCtD
Glycine—Nausea—Furosemide—coronary artery disease	0.000138	0.00111	CcSEcCtD
Glycine—Nausea—Losartan—coronary artery disease	0.000134	0.00107	CcSEcCtD
Glycine—Diarrhoea—Ramipril—coronary artery disease	0.000132	0.00106	CcSEcCtD
Glycine—Diarrhoea—Timolol—coronary artery disease	0.000129	0.00103	CcSEcCtD
Glycine—Hypersensitivity—Lisinopril—coronary artery disease	0.000129	0.00103	CcSEcCtD
Glycine—Dizziness—Ramipril—coronary artery disease	0.000127	0.00102	CcSEcCtD
Glycine—Dizziness—Timolol—coronary artery disease	0.000125	0.000999	CcSEcCtD
Glycine—Vomiting—Ramipril—coronary artery disease	0.000123	0.000982	CcSEcCtD
Glycine—Vomiting—Timolol—coronary artery disease	0.00012	0.00096	CcSEcCtD
Glycine—Diarrhoea—Lisinopril—coronary artery disease	0.00012	0.000959	CcSEcCtD
Glycine—Dizziness—Lisinopril—coronary artery disease	0.000116	0.000927	CcSEcCtD
Glycine—Nausea—Ramipril—coronary artery disease	0.000114	0.000918	CcSEcCtD
Glycine—Nausea—Timolol—coronary artery disease	0.000112	0.000897	CcSEcCtD
Glycine—Vomiting—Lisinopril—coronary artery disease	0.000111	0.000891	CcSEcCtD
Glycine—Nausea—Lisinopril—coronary artery disease	0.000104	0.000832	CcSEcCtD
Glycine—SHMT1—Metabolism—CTGF—coronary artery disease	1.07e-05	5.14e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—PSMA6—coronary artery disease	1.06e-05	5.13e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—PSMB5—coronary artery disease	1.06e-05	5.13e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—HMGCR—coronary artery disease	1.06e-05	5.09e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—GOT2—coronary artery disease	1.06e-05	5.09e-05	CbGpPWpGaD
Glycine—SLC16A10—Transmembrane transport of small molecules—PLG—coronary artery disease	1.06e-05	5.09e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—FGF1—coronary artery disease	1.06e-05	5.09e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—CSF2—coronary artery disease	1.06e-05	5.09e-05	CbGpPWpGaD
Glycine—ALAS1—Metabolism—GSTM1—coronary artery disease	1.05e-05	5.07e-05	CbGpPWpGaD
Glycine—GLYAT—Metabolism—APOE—coronary artery disease	1.05e-05	5.06e-05	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—APOE—coronary artery disease	1.05e-05	5.06e-05	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—APOE—coronary artery disease	1.05e-05	5.06e-05	CbGpPWpGaD
Glycine—GATM—Metabolism—APOE—coronary artery disease	1.05e-05	5.06e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—LPL—coronary artery disease	1.05e-05	5.05e-05	CbGpPWpGaD
Glycine—AGXT—Metabolism—GPX1—coronary artery disease	1.04e-05	5.01e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—RPS6KB1—coronary artery disease	1.04e-05	5.01e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—MEF2C—coronary artery disease	1.04e-05	5.01e-05	CbGpPWpGaD
Glycine—ALAS2—Metabolism—NOS3—coronary artery disease	1.04e-05	5.01e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—CTGF—coronary artery disease	1.04e-05	5.01e-05	CbGpPWpGaD
Glycine—GATM—Metabolism—APOA1—coronary artery disease	1.04e-05	5.01e-05	CbGpPWpGaD
Glycine—GLYAT—Metabolism—APOA1—coronary artery disease	1.04e-05	5.01e-05	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—APOA1—coronary artery disease	1.04e-05	5.01e-05	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—APOA1—coronary artery disease	1.04e-05	5.01e-05	CbGpPWpGaD
Glycine—ALAS1—Metabolism—LPL—coronary artery disease	1.03e-05	4.98e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—HMGCR—coronary artery disease	1.03e-05	4.96e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—GOT2—coronary artery disease	1.03e-05	4.96e-05	CbGpPWpGaD
Glycine—BAAT—Metabolism—AGT—coronary artery disease	1.02e-05	4.93e-05	CbGpPWpGaD
Glycine—AGXT—Metabolism—CD36—coronary artery disease	1.01e-05	4.88e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—ITGB3—coronary artery disease	1.01e-05	4.88e-05	CbGpPWpGaD
Glycine—ALAS1—Metabolism—GPX1—coronary artery disease	1.01e-05	4.85e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—GSTP1—coronary artery disease	1e-05	4.84e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—PRKCE—coronary artery disease	1e-05	4.84e-05	CbGpPWpGaD
Glycine—BAAT—Metabolism—APOE—coronary artery disease	1e-05	4.83e-05	CbGpPWpGaD
Glycine—AGXT—Metabolism—PPP2CA—coronary artery disease	1e-05	4.82e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—PPARGC1A—coronary artery disease	9.95e-06	4.8e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—HMOX1—coronary artery disease	9.91e-06	4.78e-05	CbGpPWpGaD
Glycine—BAAT—Metabolism—APOA1—coronary artery disease	9.91e-06	4.78e-05	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—CXCL8—coronary artery disease	9.88e-06	4.76e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—PPP2CA—coronary artery disease	9.83e-06	4.74e-05	CbGpPWpGaD
Glycine—ALAS1—Metabolism—CD36—coronary artery disease	9.81e-06	4.73e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—KITLG—coronary artery disease	9.78e-06	4.71e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—TGFBR2—coronary artery disease	9.78e-06	4.71e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—CAT—coronary artery disease	9.77e-06	4.71e-05	CbGpPWpGaD
Glycine—SLC16A10—Transmembrane transport of small molecules—HMOX1—coronary artery disease	9.74e-06	4.7e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—PLCB1—coronary artery disease	9.71e-06	4.68e-05	CbGpPWpGaD
Glycine—ALAS1—Metabolism—PPP2CA—coronary artery disease	9.68e-06	4.67e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—PRKCD—coronary artery disease	9.65e-06	4.66e-05	CbGpPWpGaD
Glycine—SLC36A1—Transmembrane transport of small molecules—ALB—coronary artery disease	9.62e-06	4.64e-05	CbGpPWpGaD
Glycine—AGXT—Metabolism—MTHFR—coronary artery disease	9.59e-06	4.63e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—STAT5A—coronary artery disease	9.56e-06	4.61e-05	CbGpPWpGaD
Glycine—ALAS2—Metabolism—PTGS2—coronary artery disease	9.5e-06	4.58e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—APOB—coronary artery disease	9.49e-06	4.58e-05	CbGpPWpGaD
Glycine—BAAT—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	9.49e-06	4.57e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—PLCB1—coronary artery disease	9.46e-06	4.56e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—HTR2A—coronary artery disease	9.45e-06	4.56e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—C3—coronary artery disease	9.43e-06	4.55e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—ABCA1—coronary artery disease	9.41e-06	4.54e-05	CbGpPWpGaD
Glycine—GRIN2C—Neuronal System—MAPK1—coronary artery disease	9.37e-06	4.52e-05	CbGpPWpGaD
Glycine—GRIN2A—Transmission across Chemical Synapses—MAPK1—coronary artery disease	9.34e-06	4.5e-05	CbGpPWpGaD
Glycine—SLC16A10—Transmembrane transport of small molecules—APOB—coronary artery disease	9.33e-06	4.5e-05	CbGpPWpGaD
Glycine—ALAS1—Metabolism—MTHFR—coronary artery disease	9.29e-06	4.48e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—APOB—coronary artery disease	9.24e-06	4.45e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—GSTM1—coronary artery disease	9.23e-06	4.45e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—ABCA1—coronary artery disease	9.17e-06	4.42e-05	CbGpPWpGaD
Glycine—GLYAT—Metabolism—PPARG—coronary artery disease	9.15e-06	4.41e-05	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—PPARG—coronary artery disease	9.15e-06	4.41e-05	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—PPARG—coronary artery disease	9.15e-06	4.41e-05	CbGpPWpGaD
Glycine—GATM—Metabolism—PPARG—coronary artery disease	9.15e-06	4.41e-05	CbGpPWpGaD
Glycine—AGXT—Metabolism—AGT—coronary artery disease	9.12e-06	4.4e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—GGT1—coronary artery disease	9.12e-06	4.4e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—GOT1—coronary artery disease	9.12e-06	4.4e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—LPL—coronary artery disease	9.06e-06	4.37e-05	CbGpPWpGaD
Glycine—GATM—Metabolism—POMC—coronary artery disease	9.02e-06	4.35e-05	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—POMC—coronary artery disease	9.02e-06	4.35e-05	CbGpPWpGaD
Glycine—GLYAT—Metabolism—POMC—coronary artery disease	9.02e-06	4.35e-05	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—POMC—coronary artery disease	9.02e-06	4.35e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—HIF1A—coronary artery disease	9e-06	4.34e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—AGT—coronary artery disease	8.96e-06	4.32e-05	CbGpPWpGaD
Glycine—AGXT—Metabolism—APOE—coronary artery disease	8.93e-06	4.31e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—FGF1—coronary artery disease	8.88e-06	4.28e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—GGT1—coronary artery disease	8.88e-06	4.28e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—GOT1—coronary artery disease	8.88e-06	4.28e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—GPX1—coronary artery disease	8.84e-06	4.26e-05	CbGpPWpGaD
Glycine—AGXT—Metabolism—APOA1—coronary artery disease	8.83e-06	4.26e-05	CbGpPWpGaD
Glycine—ALAS1—Metabolism—AGT—coronary artery disease	8.83e-06	4.26e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—LPL—coronary artery disease	8.82e-06	4.25e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—LEP—coronary artery disease	8.78e-06	4.24e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—APOE—coronary artery disease	8.78e-06	4.24e-05	CbGpPWpGaD
Glycine—BAAT—Metabolism—PPARG—coronary artery disease	8.73e-06	4.21e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—APOA1—coronary artery disease	8.68e-06	4.19e-05	CbGpPWpGaD
Glycine—ALAS1—Metabolism—APOE—coronary artery disease	8.65e-06	4.17e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—CD36—coronary artery disease	8.61e-06	4.15e-05	CbGpPWpGaD
Glycine—BAAT—Metabolism—POMC—coronary artery disease	8.61e-06	4.15e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—KDR—coronary artery disease	8.61e-06	4.15e-05	CbGpPWpGaD
Glycine—ALAS1—Metabolism—APOA1—coronary artery disease	8.55e-06	4.12e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—MAPK14—coronary artery disease	8.55e-06	4.12e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—PPP2CA—coronary artery disease	8.5e-06	4.1e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—ESR1—coronary artery disease	8.39e-06	4.04e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—FN1—coronary artery disease	8.28e-06	3.99e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—F2—coronary artery disease	8.28e-06	3.99e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—PPP2CA—coronary artery disease	8.27e-06	3.99e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—IL6ST—coronary artery disease	8.25e-06	3.98e-05	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—ALB—coronary artery disease	8.23e-06	3.97e-05	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—ALB—coronary artery disease	8.23e-06	3.97e-05	CbGpPWpGaD
Glycine—GATM—Metabolism—ALB—coronary artery disease	8.23e-06	3.97e-05	CbGpPWpGaD
Glycine—GLYAT—Metabolism—ALB—coronary artery disease	8.23e-06	3.97e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—GSTP1—coronary artery disease	8.19e-06	3.95e-05	CbGpPWpGaD
Glycine—ALAS1—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	8.19e-06	3.95e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—NFKBIA—coronary artery disease	8.19e-06	3.95e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—MTHFR—coronary artery disease	8.16e-06	3.93e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—PRKCD—coronary artery disease	8.13e-06	3.92e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—PPARGC1A—coronary artery disease	8.11e-06	3.91e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—HMOX1—coronary artery disease	8.08e-06	3.89e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—GSTP1—coronary artery disease	7.98e-06	3.85e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—CAT—coronary artery disease	7.97e-06	3.84e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—MTHFR—coronary artery disease	7.94e-06	3.83e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—KIT—coronary artery disease	7.93e-06	3.82e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—PPARGC1A—coronary artery disease	7.91e-06	3.81e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—HMOX1—coronary artery disease	7.87e-06	3.79e-05	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—NOS3—coronary artery disease	7.87e-06	3.79e-05	CbGpPWpGaD
Glycine—GLYAT—Metabolism—NOS3—coronary artery disease	7.87e-06	3.79e-05	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—NOS3—coronary artery disease	7.87e-06	3.79e-05	CbGpPWpGaD
Glycine—GATM—Metabolism—NOS3—coronary artery disease	7.87e-06	3.79e-05	CbGpPWpGaD
Glycine—BAAT—Metabolism—ALB—coronary artery disease	7.85e-06	3.78e-05	CbGpPWpGaD
Glycine—AGXT—Metabolism—PPARG—coronary artery disease	7.78e-06	3.75e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—CAT—coronary artery disease	7.76e-06	3.74e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—AGT—coronary artery disease	7.75e-06	3.74e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—APOB—coronary artery disease	7.74e-06	3.73e-05	CbGpPWpGaD
Glycine—AGXT—Metabolism—POMC—coronary artery disease	7.67e-06	3.7e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—GSK3B—coronary artery disease	7.61e-06	3.67e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—APOE—coronary artery disease	7.59e-06	3.66e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—HIF1A—coronary artery disease	7.57e-06	3.65e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—POMC—coronary artery disease	7.55e-06	3.64e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—CREB1—coronary artery disease	7.55e-06	3.64e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—APOB—coronary artery disease	7.54e-06	3.63e-05	CbGpPWpGaD
Glycine—ALAS1—Metabolism—PPARG—coronary artery disease	7.53e-06	3.63e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—GSTM1—coronary artery disease	7.52e-06	3.63e-05	CbGpPWpGaD
Glycine—BAAT—Metabolism—NOS3—coronary artery disease	7.51e-06	3.62e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—APOA1—coronary artery disease	7.51e-06	3.62e-05	CbGpPWpGaD
Glycine—ALAS1—Metabolism—POMC—coronary artery disease	7.43e-06	3.58e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—APOE—coronary artery disease	7.39e-06	3.56e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—LPL—coronary artery disease	7.39e-06	3.56e-05	CbGpPWpGaD
Glycine—SLC16A10—Transmembrane transport of small molecules—APOA1—coronary artery disease	7.38e-06	3.56e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—CCL2—coronary artery disease	7.38e-06	3.56e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—IL6R—coronary artery disease	7.36e-06	3.55e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—GSTM1—coronary artery disease	7.33e-06	3.54e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—APOA1—coronary artery disease	7.31e-06	3.52e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—IGF1—coronary artery disease	7.26e-06	3.5e-05	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—MAPK1—coronary artery disease	7.22e-06	3.48e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—GPX1—coronary artery disease	7.21e-06	3.47e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—LPL—coronary artery disease	7.2e-06	3.47e-05	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—PTGS2—coronary artery disease	7.2e-06	3.47e-05	CbGpPWpGaD
Glycine—GLYAT—Metabolism—PTGS2—coronary artery disease	7.2e-06	3.47e-05	CbGpPWpGaD
Glycine—GATM—Metabolism—PTGS2—coronary artery disease	7.2e-06	3.47e-05	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—PTGS2—coronary artery disease	7.2e-06	3.47e-05	CbGpPWpGaD
Glycine—GRIN2A—Neuronal System—MAPK1—coronary artery disease	7.16e-06	3.45e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—GPX1—coronary artery disease	7.02e-06	3.39e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—CD36—coronary artery disease	7.02e-06	3.38e-05	CbGpPWpGaD
Glycine—AGXT—Metabolism—ALB—coronary artery disease	7e-06	3.37e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—IL6ST—coronary artery disease	6.94e-06	3.35e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—PPP2CA—coronary artery disease	6.93e-06	3.34e-05	CbGpPWpGaD
Glycine—GPR18—GPCR downstream signaling—PIK3CA—coronary artery disease	6.9e-06	3.33e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—SERPINE1—coronary artery disease	6.89e-06	3.32e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—NOS2—coronary artery disease	6.89e-06	3.32e-05	CbGpPWpGaD
Glycine—BAAT—Metabolism—PTGS2—coronary artery disease	6.87e-06	3.31e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—CD36—coronary artery disease	6.84e-06	3.3e-05	CbGpPWpGaD
Glycine—ALAS1—Metabolism—ALB—coronary artery disease	6.78e-06	3.27e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—PPP2CA—coronary artery disease	6.75e-06	3.26e-05	CbGpPWpGaD
Glycine—AGXT—Metabolism—NOS3—coronary artery disease	6.69e-06	3.23e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—FGF2—coronary artery disease	6.67e-06	3.22e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—KIT—coronary artery disease	6.67e-06	3.22e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—MTHFR—coronary artery disease	6.65e-06	3.21e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—PPARG—coronary artery disease	6.62e-06	3.19e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—NOS3—coronary artery disease	6.58e-06	3.17e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—POMC—coronary artery disease	6.52e-06	3.15e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—MTHFR—coronary artery disease	6.48e-06	3.12e-05	CbGpPWpGaD
Glycine—ALAS1—Metabolism—NOS3—coronary artery disease	6.48e-06	3.12e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—GSK3B—coronary artery disease	6.4e-06	3.09e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—JAK2—coronary artery disease	6.4e-06	3.08e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—CREB1—coronary artery disease	6.35e-06	3.06e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—AGT—coronary artery disease	6.32e-06	3.05e-05	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—PIK3CA—coronary artery disease	6.27e-06	3.02e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—IL6R—coronary artery disease	6.19e-06	2.99e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—APOE—coronary artery disease	6.19e-06	2.99e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—AGT—coronary artery disease	6.16e-06	2.97e-05	CbGpPWpGaD
Glycine—GARS—Gene Expression—AKT1—coronary artery disease	6.14e-06	2.96e-05	CbGpPWpGaD
Glycine—AGXT—Metabolism—PTGS2—coronary artery disease	6.12e-06	2.95e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—APOA1—coronary artery disease	6.12e-06	2.95e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—APOE—coronary artery disease	6.03e-06	2.91e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—APOA1—coronary artery disease	5.96e-06	2.88e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—ALB—coronary artery disease	5.95e-06	2.87e-05	CbGpPWpGaD
Glycine—ALAS1—Metabolism—PTGS2—coronary artery disease	5.93e-06	2.86e-05	CbGpPWpGaD
Glycine—SLC16A10—Transmembrane transport of small molecules—ALB—coronary artery disease	5.85e-06	2.82e-05	CbGpPWpGaD
Glycine—ALAS2—Metabolism—PIK3CA—coronary artery disease	5.84e-06	2.82e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—CXCL8—coronary artery disease	5.84e-06	2.81e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—SERPINE1—coronary artery disease	5.8e-06	2.8e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—NOS3—coronary artery disease	5.69e-06	2.74e-05	CbGpPWpGaD
Glycine—GPR18—GPCR downstream signaling—AKT1—coronary artery disease	5.64e-06	2.72e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—FGF2—coronary artery disease	5.62e-06	2.71e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—CASP3—coronary artery disease	5.59e-06	2.69e-05	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—IL6—coronary artery disease	5.55e-06	2.68e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—NOS3—coronary artery disease	5.54e-06	2.67e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—CCND1—coronary artery disease	5.44e-06	2.62e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—PPARG—coronary artery disease	5.39e-06	2.6e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—JAK2—coronary artery disease	5.38e-06	2.6e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—POMC—coronary artery disease	5.32e-06	2.56e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—MMP9—coronary artery disease	5.28e-06	2.55e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—PPARG—coronary artery disease	5.26e-06	2.53e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—PTGS2—coronary artery disease	5.2e-06	2.51e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—POMC—coronary artery disease	5.18e-06	2.5e-05	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—AKT1—coronary artery disease	5.12e-06	2.47e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—PTGS2—coronary artery disease	5.07e-06	2.44e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—ALB—coronary artery disease	4.85e-06	2.34e-05	CbGpPWpGaD
Glycine—ALAS2—Metabolism—AKT1—coronary artery disease	4.77e-06	2.3e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—VEGFA—coronary artery disease	4.74e-06	2.29e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—ALB—coronary artery disease	4.73e-06	2.28e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—NOS3—coronary artery disease	4.64e-06	2.24e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—NOS3—coronary artery disease	4.52e-06	2.18e-05	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—PIK3CA—coronary artery disease	4.43e-06	2.14e-05	CbGpPWpGaD
Glycine—GATM—Metabolism—PIK3CA—coronary artery disease	4.43e-06	2.14e-05	CbGpPWpGaD
Glycine—GLYAT—Metabolism—PIK3CA—coronary artery disease	4.43e-06	2.14e-05	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—PIK3CA—coronary artery disease	4.43e-06	2.14e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—TGFB1—coronary artery disease	4.35e-06	2.1e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—MAPK1—coronary artery disease	4.27e-06	2.06e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—PTGS2—coronary artery disease	4.24e-06	2.05e-05	CbGpPWpGaD
Glycine—BAAT—Metabolism—PIK3CA—coronary artery disease	4.22e-06	2.04e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—PTGS2—coronary artery disease	4.13e-06	1.99e-05	CbGpPWpGaD
Glycine—AGXT—Metabolism—PIK3CA—coronary artery disease	3.77e-06	1.82e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—PIK3CA—coronary artery disease	3.7e-06	1.79e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—TGFB1—coronary artery disease	3.66e-06	1.77e-05	CbGpPWpGaD
Glycine—ALAS1—Metabolism—PIK3CA—coronary artery disease	3.65e-06	1.76e-05	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—AKT1—coronary artery disease	3.62e-06	1.74e-05	CbGpPWpGaD
Glycine—GATM—Metabolism—AKT1—coronary artery disease	3.62e-06	1.74e-05	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—AKT1—coronary artery disease	3.62e-06	1.74e-05	CbGpPWpGaD
Glycine—GLYAT—Metabolism—AKT1—coronary artery disease	3.62e-06	1.74e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—MAPK1—coronary artery disease	3.59e-06	1.73e-05	CbGpPWpGaD
Glycine—BAAT—Metabolism—AKT1—coronary artery disease	3.45e-06	1.66e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—IL6—coronary artery disease	3.28e-06	1.58e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—PIK3CA—coronary artery disease	3.2e-06	1.54e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—PIK3CA—coronary artery disease	3.12e-06	1.5e-05	CbGpPWpGaD
Glycine—AGXT—Metabolism—AKT1—coronary artery disease	3.08e-06	1.48e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—AKT1—coronary artery disease	3.02e-06	1.46e-05	CbGpPWpGaD
Glycine—ALAS1—Metabolism—AKT1—coronary artery disease	2.98e-06	1.44e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—IL6—coronary artery disease	2.76e-06	1.33e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—AKT1—coronary artery disease	2.62e-06	1.26e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—PIK3CA—coronary artery disease	2.61e-06	1.26e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—AKT1—coronary artery disease	2.55e-06	1.23e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—PIK3CA—coronary artery disease	2.54e-06	1.23e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—AKT1—coronary artery disease	2.13e-06	1.03e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—AKT1—coronary artery disease	2.08e-06	1e-05	CbGpPWpGaD
